Your provider determines whether you meet the clinical criteria for treatment based on your individual health profile
What does clinical research say about GLP-1 safety and heart rate
What Changed in 2025: The Shortage Ended and the Compounding Window Closed For a couple of years, compounded versions of semaglutide and tirzepatide were widely availableoften faster to get and cheaper than the brand-name pens
Other relevant factors, such as provider preferences, health plan details, and specific patient characteristics (e.g., social needs, family history), are unavailable, potentially leading to unmeasured confounding
Role of IGF-I in skeletal muscle mass maintenance
Injection site reactions Some may experience skin irritation including redness, pain, swelling at the site of the injection